Dover has entered into a definitive settlement to acquire Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s merchandise will increase Dover’s biopharma single-use manufacturing providing, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue during the full yr 2022.
When the deal closes, Malema will turn into part of the PSG enterprise unit within Dover’s Pumps & Process Solutions segment.
“We see an amazing long-term progress alternative in the bioprocessing trade driven by a robust and rising pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of more efficient single-use manufacturing processes supports a strong outlook for our choices of single-use parts to end-customers. We imagine that pairing Malema’s know-how with our existing portfolio of single-use pumps for biopharma processing will greatly improve the accuracy and value proposition of our options to our prospects.”
“We are methodically building out our biopharma platform via proactive capability additions, new product development, and opportunistic acquisitions of highly-attractive niche component applied sciences,” said Richard Tobin, president and CEO of Dover. “ เกรดวัดแรงดัน represents a strategic and highly-complementary flow-control and sensing technology and additional strengthens our sensor portfolio with new proprietary technology. In addition to attractive biopharma functions, we expect robust development within the semiconductor area on the capability enlargement and re-shoring tailwinds.”
Share